Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R JORGENSON

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 26, 2021
Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristicsIsabel Breyer, Ban Dodin, Arjang Djamali, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2022
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesHanna L Kleiboeker, Margaret R Jorgenson, Glen E Leverson, et al.
Transplantation Proceedings|February 13, 2021
Outcomes of Delayed Graft Function in Kidney Transplant Recipients Stratified by Histologic Biopsy FindingsStacey Rolak, Arjang Djamali, Didier A Mandelbrot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2019
Evaluation of infectious risk and outcomes in the hmong renal transplant populationMargaret R Jorgenson, Brianna Cardinale, Jillian L Descourouez, et al.
Clinical Transplantation|December 18, 2025
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of CareHanna L Kleiboeker, Margaret R Jorgenson, Michael J Scolarici, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 26, 2021
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Neetika Garg, et al.
Clinical Transplantation|November 16, 2022
Pre-transplant hypoalbuminemia is not associated with worse short-term outcomes among kidney transplant recipientsIsabel Breyer, Brad C Astor, Aniruddha Srivastava, et al.
The Annals of Pharmacotherapy|January 16, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ TransplantJillian L Descourouez, Hanna Kleiboeker, Christopher M Saddler, et al.
Transplantation Proceedings|February 14, 2024
Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant RecipientsHanna Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Clinical Transplantation|December 11, 2023
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern eraMargaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 26, 2021
Risk factors and outcomes of BK viremia among deceased donor kidney transplant recipients based on donor characteristicsIsabel Breyer, Ban Dodin, Arjang Djamali, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 3, 2022
Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesHanna L Kleiboeker, Margaret R Jorgenson, Glen E Leverson, et al.
Transplantation Proceedings|February 13, 2021
Outcomes of Delayed Graft Function in Kidney Transplant Recipients Stratified by Histologic Biopsy FindingsStacey Rolak, Arjang Djamali, Didier A Mandelbrot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 9, 2019
Evaluation of infectious risk and outcomes in the hmong renal transplant populationMargaret R Jorgenson, Brianna Cardinale, Jillian L Descourouez, et al.
Clinical Transplantation|December 18, 2025
De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of CareHanna L Kleiboeker, Margaret R Jorgenson, Michael J Scolarici, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 26, 2021
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipientsMargaret R Jorgenson, Jillian L Descourouez, Neetika Garg, et al.
Clinical Transplantation|November 16, 2022
Pre-transplant hypoalbuminemia is not associated with worse short-term outcomes among kidney transplant recipientsIsabel Breyer, Brad C Astor, Aniruddha Srivastava, et al.
The Annals of Pharmacotherapy|January 16, 2025
The UW Experience: Feasibility of De Novo Letermovir for Primary Prophylaxis After Abdominal Solid Organ TransplantJillian L Descourouez, Hanna Kleiboeker, Christopher M Saddler, et al.
Transplantation Proceedings|February 14, 2024
Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant RecipientsHanna Kleiboeker, Jillian L Descourouez, Lucas T Schulz, et al.
Clinical Transplantation|December 11, 2023
Incidence and outcomes of fever of unknown origin after kidney transplant in the modern eraMargaret R Jorgenson, Sandesh Parajuli, Hanna L Kleiboeker, et al.
Pageof 8